All Perrigo articles
-
Business
Perrigo nabs US rights to AZ Crohn’s drug
Irish generics maker evades Mylan takeover bid and expands gastroenterology portfolio
-
Business
Job cuts at Daiichi, Perrigo and Cabot
Staff reductions aimed at cutting costs or, in Perrigo’s case, fending off a takeover bid
-
BusinessMerger fever sweeps pharma
The life sciences sector has been gripped by a mergers and acquisition frenzy, and it looks set to continue. But what does it mean for the industry?
-
BusinessGenerics firms in three-way takeover battle
Mylan is chasing Perrigo, while fending off advances from Teva
-
Business
Generics giant Mylan offers $30 billion for Perrigo
Mylan makes ambitious takeover offer just weeks after Abbott aquisition closes
-
Business
Perrigo to buy Omega Pharma for €3.6bn
Deal strengthens Perrigo’s over-the-counter portfolio and pushes strongly into Europe
-
Business
Lumara splits and sells to AMAG and Perrigo
Lumara has just emerged from bankruptcy and brings a drug for suppressing pre-term birth, plus other women’s health products
-
Business
Perrigo bags Elan and its bargain Irish tax rates
$8.6bn deal ends Elan’s takeover battle with Royalty Pharma